If approved, GSK's depemokimab will be the first ultra-long-acting biologic that requires only one dose every six months.

GSK announces depemokimab applications accepted for review in China and Japan for asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 17:00 Hrs [IS ...

Swiss biopharma company BioVersys said on Wednesday it had launched an initial public offering on the SIX stock exchange priced at 36 Swiss francs ($39.84) per share.

The Oral Care Market growth is driven by increasing awareness, smart oral hygiene products, and eco-friendly innovations.Pune, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Oral Care Market Size & Growth Analysis ...

Asia Pacific pharmaceutical manufacturing industry market will grow by 11.3% annually with a total addressable market cap of $57.26 billion over 2023-2032. The growth is driven by the increased drug ...

Request To Download Free Sample of This Strategic Report@ Highlighted with 59 tables and 54 figures, this 141-page report ?Asia Pacific Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, ...

German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, January 28, 2025. REUTERS/Staff/File Photo World markets were suddenly looking calmer on Wednesday as ...

In 2006, Novartis announced the creation of a biomedical R&D centre in Shangai, China. In 2007, Novartis sold its non-core business divestments of the Gerber and Medical Nutrition Business Units ...

Egypt’s president has rejected a suggestion by U.S. President Donald Trump that his country take in displaced Palestinians ...

Chinese AI app DeepSeek has limited new user registrations due to widespread cyberattacks. The app, developed by Hangzhou-based startup DeepSeek, surpassed OpenAI’s ChatGPT as Apple’s top ...

The VH1 Save the Music Foundation never had any problem getting attention in the late ’90s when it launched with a party ...